Red Cell Distribution Width Is Associated with Presence, Stage, and Grade in Patients with Renal Cell Carcinoma
Table 1
Description and comparison of clinical and laboratory characteristics of the study subjects.
Variables
RCC ()
Controls ()
value
Age (years)
0.122
Gender (male/female)
210/108
146/92
0.284
BMI ( (%))
0.370
<25
152 (47.80)
124 (52.10)
≥25
166 (52.20)
114 (47.90)
Hypertension ( (%))
120 (37.74)
86 (36.13)
0.723
Diabetes mellitus ( (%))
46 (14.47)
23 (9.66)
0.093
Smoking ( (%))
63 (19.81)
29 (12.18)
0.021
RDW (%)
<0.001
HB (g/L)
0.001
MCV (fL)
0.013
Platelet (109/L)
0.001
WBC (109/L)
<0.001
Albumin (g/L)
<0.001
ESR (mm/h)
11.00 (5.00–19.00)
6.00 (3.00–10.00)
<0.001
Side ( (%))
Left-sided
135 (42.45)
131 (55.04)
Right-sided
176 (55.35)
96 (40.34)
Two-sided
7 (2.20)
11 (4.62)
Pathologic type ( (%))
Clear cell carcinoma
282 (88.68)
Papillary renal cell carcinoma
15 (4.72)
Chromophobe renal cell carcinoma
11 (3. 46)
Others
10 (3.14)
Stage at diagnosis ( (%))
T1
239 (75.16)
T2
28 (8.81)
T3
45 (14.15)
T4
6 (1.89)
M1
20 (6.29)
M0
298 (93.71)
Fuhrman grading of clear cell carcinoma ( (%))
Grade I
22 (7.80)
Grades I-II
35 (12.41)
Grade II
129 (45.74)
Grades II-III
41 (14.54)
Grade III
47 (16.67)
Grades III-IV
7 (2.48)
Grade IV
1 (0.35)
Data are expressed as (%), median (IQR), or mean ± SD. BMI: body mass index; RDW: red cell distribution width; HB: hemoglobin; MCV: mean cell volume; WBC: white blood cell; ESR: erythrocyte sedimentation rate.
